On July 13, the Substance Abuse and Psychological Well being Providers Administration (SAMHSA) introduced that it had revised 42 C.F.R. Half 2, the Confidentiality of Substance Use Dysfunction Affected person Information laws to facilitate higher care coordination in response to the opioid epidemic. The revisions to Half 2 have been made as a part of a joint effort amongst federal companies analyzing how their laws could be revised to incentivize care coordination and enhance affected person care.
Underneath 42 C.F.R. Half 2, data created by a federally assisted substance use dysfunction program that comprise affected person figuring out info might solely be disclosed with written consent from the affected person, or in a couple of different restricted circumstances. Though SAMHSA didn’t change the essential construction of the confidentiality protections underneath Half 2, the company did search to make care coordination, claims administration, coaching, affected person security, high quality enchancment and program integrity actions simpler for suppliers.
Underneath the revised guidelines, non-opioid therapy program suppliers and non-central registry treating suppliers might question a central registry to find out whether or not their sufferers are already receiving opioid therapy by means of different suppliers. The revised guidelines additionally clarified and expanded disclosures for “functions of fee and heath care operations.” The expanded record consists of case administration and care coordination actions. This revision higher aligns the Half 2 guidelines with the HIPAA Privateness Rule that allows disclosure of an individual’s protected well being info for functions of care coordination and case administration, as these actions are thought of well being care operations underneath HIPAA.
© Steptoe & Johnson PLLC. All Rights Reserved.Nationwide Legislation Evaluate, Quantity X, Quantity 206